Bicalutamide is an antiandrogen medication for prostate cancer, marketed by AstraZeneca PLC as Casodex with 29 DMF and 12 MF approved before 2021 Q3.
Prochem implemented process validation with batch size above 100 KG in 2019, and can provide finished product as white powder with above 99.90% purity.
Product Name: Bicalutamide
CAS Number: 90357-06-5
Indication: Prostate cancer
Specification: USP 42
Certificate: PIC/S GMP certificate of bay factory / DMF from TFDA
Non-infringement Description: